HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 23

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Dec 1, 2004; 10(23): 3506-3510
Published online Dec 1, 2004. doi: 10.3748/wjg.v10.i23.3506

Full Size Figure Download Figure

Figure 4 Stent patency of the two groups.

Citation: Chen Y, Wang XL, Yan ZP, Cheng JM, Wang JH, Gong GQ, Qian S, Luo JJ, Liu QX. HDR-¹⁹²Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice. World J Gastroenterol 2004; 10(23): 3506-3510
URL: https://www.wjgnet.com/1007-9327/full/v10/i23/3506.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i23.3506

Chen Y, Wang XL, Yan ZP, Cheng JM, Wang JH, Gong GQ, Qian S, Luo JJ, Liu QX. HDR-¹⁹²Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice. World J Gastroenterol 2004; 10(23): 3506-3510 [PMID: 15526374 DOI: 10.3748/wjg.v10.i23.3506]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.